Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
ModernaTX, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pierre Fabre Medicament
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Chinese PLA General Hospital
University Hospital, Basel, Switzerland
Institut Pasteur du Cambodge
National Taiwan University Hospital
Children's Hospital Medical Center, Cincinnati
Baylor College of Medicine
Institute of Hematology & Blood Diseases Hospital, China
Centre Hospitalier Universitaire de Nīmes
National Institutes of Health Clinical Center (CC)
University of Aarhus
Stanford University
ModernaTX, Inc.
Sun Yat-sen University
The Affiliated Hospital of Xuzhou Medical University
National Health Research Institutes, Taiwan
Stanford University
New York Medical College
Baylor College of Medicine
Baylor College of Medicine
Columbia University
Viracta Therapeutics, Inc.
University Hospital Freiburg
Marengo Therapeutics, Inc.
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
ModernaTX, Inc.
Maisonneuve-Rosemont Hospital
Pediatric Transplantation & Cellular Therapy Consortium
Centre Hospitalier Universitaire de Nice
Atara Biotherapeutics
University of California, San Francisco
Sun Yat-sen University
University Hospital, Basel, Switzerland
University Hospital, Basel, Switzerland
Sun Yat-sen University
Technical University of Munich
Columbia University
National University Hospital, Singapore
Atara Biotherapeutics
Moorfields Eye Hospital NHS Foundation Trust
Labo'Life
University of California, San Diego
The First Affiliated Hospital of Soochow University